reconstituting tirzepatide chart Reconstitution: 5mg + 2mL (2026) switching to retatrutide from tirzepatide

While GLP-1 agonists offer promising benefits, they also come with potential side effects and risks, including gastrointestinal issues and a serious warning about the risk of thyroid cancer

For cell studies, 96-well plates were coated with 100 L of 10 mg/mL Matrigel (BD Biosciences) for 2 h at room temperature

Guidance does

A slight decrease in appetite

Semaglutide GLP-1 injections offer a highly effective weight loss solution, helping patients reduce appetite, control cravings, and achieve sustainable weight loss

Furthermore, the selective GCGR antagonist LY2409021 (1 mol/l) effectively suppressed GCG-induced insulin secretion but had no impact on the triagonist-enhanced GSIS in WT islets (Fig